Veterinary Medicines

OXITETRACICLINA FP 600 mg/g pulbere pentru utilizare în apa de băut

Authorised
  • Oxytetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
OXITETRACICLINA FP 600 mg/g pulbere pentru utilizare în apa de băut
Active substance:
  • Oxytetracycline hydrochloride
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • Buccal use

Product details

Active substance and strength:
  • Oxytetracycline hydrochloride
    600.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Buccal use
    • Pig
      • Meat and offal
        5
        day
    • Chicken (broiler)
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA06
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Pasteur Filiala Filipesti S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 160129
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 18/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."